Trial Supports GLP-1 After Underwhelming Metabolic Surgery
(MedPage Today) -- Adding a GLP-1 receptor agonist to lifestyle intervention helped to bolster weight loss in patients with poor outcomes following primary metabolic surgery, the BARI-OPTIMISE randomized trial found.
Looking at 70 individuals...
Source: MedPage Today Endocrinology - Category: Endocrinology Source Type: news
More News: Endocrinology | Weight Loss